On July 9, 2021, the Biden Administration issued an executive order (EO), “Promoting Competition in the American Economy,” to address corporate consolidation, lack of competition and high prices for consumers, and low wages.[i] The health care portion of the EO focuses on improving competition to address health care prices and access to care in four [...] Read More
Today, President Trump released his FY 2020 budget proposal, including $1.313 trillion in discretionary proposals (a reduction of $24 billion from his FY 2019 proposal). On the healthcare front, the budget requests an additional $500 million in funding devoted to childhood cancer research, $291 million to eliminate most new HIV infections within 5 years and [...] Read More
In last night’s State of the Union, President Trump addressed a number of health care related issues including prescription drug pricing, health care costs, and the defeat of HIV in the United States. On Prescription Drugs “Already, as a result of my Administration's efforts, in 2018 drug prices experienced their single largest decline in 46 years. [...] Read More
Healthcare will be first on the docket when the 116th Congress convenes in January, according to Rep. Don Beyer, speaker at this month’s gathering of the Northern Virginia Health Policy Forum. Mr. Beyer, who was just reelected to a third term, said he is looking forward to serving in the House majority with the hope [...] Read More
Following the release of an HHS report on international drug pricing, President Trump announced a new Department of Health and Human Services (HHS) initiative to index pricing for Medicare Part B drugs to international prices. The advance notice of proposed rulemaking solicits comments on a demonstration program HHS is considering that would test changes to [...] Read More
In the Bipartisan Budget Act of 2018 the Congressional Budget Office underestimated – by $4 billion – the amount Medicare would save due to changes in Medicare Part D. Instead of saving $7.7 billion, Medicare will actually save $11.8 billion. The savings come from an increase in the government mandated discount that drug manufacturers must offer enrollees [...] Read More